Stephen V Liu, MD
@stephenvliu
Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo
ID: 377425889
https://www.medstarhealth.org/doctors/stephen-liu-md 21-09-2011 15:17:53
19,19K Tweet
26,26K Followers
3,3K Following
CROWN results from #ASCO24 Journal of Clinical Oncology: phase III 1L lorlatinib vs crizotinib in #ALK NSCLC. With 5y median f/u, median PFS not reached. 5y PFS rate 60% with lorlatinib (8% with crizotinib), median time to intracranial progression NR vs 16.4m (HR 0.06). ascopubs.org/doi/10.1200/JC…